BindingDB logo
myBDB logout

null

SMILES: CCN(CCO)Cc1ccc2Nc3nccc(Nc4cc(O)c(Cl)cc4F)c3C(=O)Nc2c1

InChI Key: InChIKey=JRHZSLDMBCJCRQ-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 227829   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Platelet-derived growth factor receptor beta


(Homo sapiens (Human))
BDBM227829
PNG
(4-[(4-Chloro-2-fluoro-5-hydroxyphenyl)amino]-8-{[e...)
Show SMILES CCN(CCO)Cc1ccc2Nc3nccc(Nc4cc(O)c(Cl)cc4F)c3C(=O)Nc2c1
Show InChI InChI=1S/C23H23ClFN5O3/c1-2-30(7-8-31)12-13-3-4-16-19(9-13)29-23(33)21-17(5-6-26-22(21)28-16)27-18-11-20(32)14(24)10-15(18)25/h3-6,9-11,31-32H,2,7-8,12H2,1H3,(H,29,33)(H2,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.793n/an/an/an/a7.522



Bayer Pharma Aktiengesellschaft

US Patent


Assay Description
The kinase used was a recombinant fusion protein composed of N-terminal GST and a C-terminal fragment of human PDGFRβ (amino acids R561-L1106), expr...


US Patent US10047096 (2018)


BindingDB Entry DOI: 10.7270/Q23R0VW4
More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM227829
PNG
(4-[(4-Chloro-2-fluoro-5-hydroxyphenyl)amino]-8-{[e...)
Show SMILES CCN(CCO)Cc1ccc2Nc3nccc(Nc4cc(O)c(Cl)cc4F)c3C(=O)Nc2c1
Show InChI InChI=1S/C23H23ClFN5O3/c1-2-30(7-8-31)12-13-3-4-16-19(9-13)29-23(33)21-17(5-6-26-22(21)28-16)27-18-11-20(32)14(24)10-15(18)25/h3-6,9-11,31-32H,2,7-8,12H2,1H3,(H,29,33)(H2,26,27,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.31n/an/an/an/a7.0n/a



Bayer Pharma Aktiengesellschaft

US Patent


Assay Description
The kinase used was a recombinant fusion protein composed of N-terminal GST and a C-terminal fragment of human KDR (amino acids D807-V1356), expresse...


US Patent US10047096 (2018)


BindingDB Entry DOI: 10.7270/Q23R0VW4
More data for this
Ligand-Target Pair